Publications
Bioenergetics
T.B. Sundberg, L. Swenson, D.R. Wahl, A.W. Opipari, G.D. Glick. “Apoptotic Signaling Activated by Modulation of the F0F1-ATPase: Implications for Selective Killing of Autoimmune Lymphocytes,” Journal of Pharmacology and Experimental Therapeutics, 2009; 331: 437.
PDF
P.L. Toogood. “Mitochondrial drugs,” Current Opinion in Chemical Biology, 2008; 12: 457.
PDF
K.M. Johnson, J. Cleary, C.A. Fierke, A.W. Opipari Jr., G.D. Glick. “Mechanistic basis for therapeutic targeting of the mitochondrial F1Fo-ATPase,”ACS Chemical Biology, 2006; 1: 304.
PDF
K.M. Johnson, X. Chen, A. Boitano, L. Swenson, A.W. Opipari Jr., G.D. Glick. “Identification and validation of the mitochondrial F1F0-ATPase as the molecular target of the immunomodulatory benzodiazepine Bz-423,” Chemistry & Biology, 2005; 12: 485.
PDF
N.B. Blatt, J.J. Bednarski, R.E. Warner, F. Leonetti, K.M. Johnson, A. Boitano, R. Yung, B.C. Richardson, K.J. Johnson, J.A. Ellman, A.W. Opipari Jr., G.D. Glick. “Benzodiazepine-induced superoxide signals B cell apoptosis: mechanistic insight and potential therapeutic utility,” Journal of Clinical Investigation, 2002; 110: 1123.
PDF
Th17
C.K. Glass, K. Saijo. “Nuclear receptor transrepression pathways that regulate inflammation in macrophages and T cells,” Nature Reviews Immunology, 2010; 10: 365.
PDF
P. Miossec, T. Korn, V.K. Kuchroo. “Interleukin-17 and Type 17 Helper T Cells,” New England Journal of Medicine, 2009; 361:888.
PDF
L.A. Tesmer, S.K. Lundy, S. Sarkar, D.A. Fox. “Th17 cells in human disease,” Immunological Reviews, 2008; 223: 87.
PDF
I. Ivanov, B.S. McKenzie, L. Zhou, C.E. Tadokoro, A. Lepelley, J.J. Lafaille, D.J. Cua, D.R. Littman. “The orphan nuclear receptor RORgammat directs the differentiation program of proinflammatory IL-17+ T helper cells.” Cell. 2006; 126: 1121.
PDF